| Long name: |
ALEXA FLUOR 488 Conjugated, E2F1 (Ser337) Polyclonal Antibody |
| Also known as: |
Anti-E2F1 Ser337 PAb ALEXA FLUOR 488 |
| Category: |
Conjugated Primary Antibodies |
| Conjugated with: |
488, ALEXA FLUOR® |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
E2F1 Ser337 |
| Specificity: |
This is a highly specific antibody against E2F1 Ser337 |
| Modification: |
Phosphorylation |
| Modification Site: |
Ser337 |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
KLH conjugated synthetic phosphopeptide derived from human E2F1 around the phosphorylation site of Ser337 |
| Gene ID Number: |
1869 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Human |
| Cross-reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the antigen: |
E2F1 is proposed to be involved in several cellular processes that range from tumor suppressor, E2F1 overexpression can also drive cells into apoptosis, E2F2 and E2F3, The E2F proteins contain several evolutionally conserved domains found in most members of the family, These domains include a DNA binding domain, This protein and another 2 members, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain, cell progression and oncogenesis, have an additional cyclin binding domain, resulting in an altered rate of gene transcription, such as the retinoblastoma p107 protein, which associate with negative regulators, E2F's are DNA binding proteins |
| Purification: |
Purified by Protein A |
| Storage conditions: |
50% glycerol and 0, Keep refrigerated at 2 to 8 degrees Celcius for up to one year, 09% sodium azide, Store this antibody in aqueous buffered solution containing 1% BSA |
| Excitation emission: |
499nm/519nm |
| Synonyms: |
RBP3 |
| Properties: |
ALEXA FLUOR they should be stored frozen at - 24°, Alexa Fluor 488 has the same range to that of fluorescein isothiocyanate (FITC), Also Alexa Fluor 488 is pH stable, As a result of this photo stability, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies, It is distinguished in the FL1 of a FACS-Calibur or FACScan, has a very high photo stability, it has turned into an antibody for fluorescent microscopy and FACS FLOW cytometry, yet the E2F1 (Ser337) Antibody, C, C for long term storage and for short term at + 5°, For facs or microscopy Alexa 1 conjugate |
| Conjugation: |
Alexa Fluor |
| Gene target: |
E2F1 (Ser337) |
| Short name: |
E2F1 (Ser337) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Label: |
ALEXA FLUOR 488 |
| Alternative name: |
ALEXA FLUOR 488, E2F transcription factor 1 (Ser337) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BT, DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006915 and apoptotic process and biological process this GO :0007219 and Notch signaling pathway and biological process this GO :0007283 and spermatogenesis and biological process this GO :0008134 and transcription factor binding and molecular function this GO :0008283 and cell proliferation and biological process this GO :0008630 and intrinsic apoptotic signaling pathway in response to DNA damage and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0030900 and forebrain development and biological process this GO :0035189 and Rb-E2F complex and cellular component this GO :0043276 and anoikis and biological process this GO :0043565 and sequence-specific DNA binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0045892 and negative regulation of transcription, DNA-templated and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048146 and positive regulation of fibroblast proliferation and biological process this GO :0048255 and mRNA stabilization and biological process this GO :0051726 and regulation of cell cycle and biological process this GO :0071398 and cellular response to fatty acid and biological process this GO :0071456 and cellular response to hypoxia and biological process this GO :0071930 and negative regulation of transcription involved in G1/S transition of mitotic cell cycle and biological process this GO :0072332 and intrinsic apoptotic signaling pathway by p53 class mediator and biological process this GO :0097193 and intrinsic apoptotic signaling pathway and biological process this GO :1900740 and positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway and biological process this GO :1990086 and lens fiber cell apoptotic process and biological process this GO :2000045 and regulation of G1/S transition of mitotic cell cycle and biological process, E2F-1 and RBAP1 and RBBP3 and RBP3, E2F1 and IDBG-67214 and ENSG00000101412 and 1869, E2f1 and IDBG-210416 and ENSMUSG00000027490 and 13555, nuclei, sequence-specific DNA binding, this GO :0000077 and DNA damage checkpoint and biological process this GO :0000080 and mitotic G1 phase and biological process this GO :0000082 and G1/S transition of mitotic cell cycle and biological process this GO :0000085 and mitotic G2 phase and biological process this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0000278 and mitotic cell cycle and biological process this GO :0001047 and core promoter binding and molecular function this GO :0003677 and DNA binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0003714 and transcription corepressor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005667 and transcription factor complex and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006351 and transcription, this GO :0001047 : core promoter binding, this GO :0001047 : core promoter binding and also this GO :0003677 : DNA binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0003714 : transcription corepressor activity and also this GO :0005515 : protein binding and also this GO :0008134 : transcription factor binding and also this GO :0043565 : sequence-specific DNA binding, this GO :0003677 : DNA binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0003714 : transcription corepressor activity, this GO :0005515 : protein binding, this GO :0008134 : transcription factor binding, this GO :0043565 : sequence-specific DNA binding, 78028 and IDBG-641855 and ENSBTAG00000003971 and 535369, E2F transcription factor 1 |
| Identity: |
3113 |
| Gene: |
E2F1 |
More about : E2F1 |
| Long gene name: |
E2F transcription factor 1 |
| Synonyms gene: |
RBBP3 |
| Locus: |
20q11, 22 |
| Discovery year: |
1993-06-29 |
| Entrez gene record: |
1869 |
| Pubmed identfication: |
8964493 |
| Classification: |
E2F transcription factors |
| Havana BLAST/BLAT: |
OTTHUMG00000032265 |